Early kidney damage induced by subchronic exposure to PM2.5 in rats

Particle and Fibre Toxicology

Volumn 13, Issue 1, 2016, Pages

  Aztatzi Aguilar, O G ^a   Uribe Ramirez M ^a   Narvaez Morales J ^a   De Vizcaya Ruiz, A ^a   Barbier, O ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Angiotensin and bradykinin systems; Antioxidant response; Cardiovascular diseases; Inflammation; Kidney biomarkers

Indexed keywords

ANGIOTENSIN; BETA 2 MICROGLOBULIN; BRADYKININ; CYSTATIN C; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; RANTES; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR; CYTOKINE; PARTICULATE MATTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE MARKER; FLUID INTAKE; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY INJURY; LUNG INJURY; LUNG LAVAGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUSPENDED PARTICULATE MATTER; UPREGULATION; URINE VOLUME; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; DRUG EFFECTS; KIDNEY; PARTICULATE MATTER; SPRAGUE DAWLEY RAT; TOXICITY; URINE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; KIDNEY; MALE; PARTICULATE MATTER; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85003475073     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/s12989-016-0179-8     Document Type: Article

References (75)

1. Pope III CA, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manage Assoc. 2006;56:709-42.
2. Mutlu GM, Green D, Bellmeyer A, Baker CM, Burgess Z, Rajamannan N, Christman JW, Foiles N, Kamp DW, Ghio AJ, et al. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Investig. 2007;117:2952-61.
3. Osornio-Vargas AR, Bonner JC, Alfaro-Moreno E, Martínez L, García-Cuellar C, Rosales SP-d-L, Miranda J, Rosas I. Proinflammatory and cytotoxic effects of Mexico City air pollution particulate matter in vitro are dependent on particle size and composition. Environ Health Perspect. 2003;111:1289.
4. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect. 2003;111:455.
5. Pope 3rd CA, Hansen ML, Long RW, Nielsen KR, Eatough NL, Wilson WE, Eatough DJ. Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects. Environ Health Perspect. 2004;112:339.
6. Aztatzi-Aguilar OG, Uribe-Ramírez M, Arias-Montaño JA, Barbier O, De Vizcaya-Ruiz A. Acute and subchronic exposure to air particulate matter induces expression of angiotensin and bradykinin-related genes in the lungs and heart: Angiotensin-II type-I receptor as a molecular target of particulate matter exposure. Particle And Fibre Toxicology. 2015;12:17.
7. DiBona GF. Neural control of the kidney: functionally specific renal sympathetic nerve fibers. Am J Physiol Regul Integr Comp Physiol. 2000;279:R1517-24.
8. Levin A. Prevalence of cardiovascular damage in early renal disease. Nephrol Dial Transplant. 2001;16:7-11.
9. Amann K, Wanner C, Ritz E. Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol. 2006;17:2112-9.
10. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension. 2005;45:1042-9.
11. Segura J, Campo C, Gil P, Roldán C, Vigil L, Rodicio JL, Ruilope LM. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients. J Am Soc Nephrol. 2004;15:1616-22.
12. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3:1526-33.
13. Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care. 2004;10:476-82.
14. Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A. Urinary clusterin, cystatin C,[beta] 2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol. 2010;28:463-9.
15. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71:967-70.
16. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci. 2008;101:159-70.
17. Johri N, Jacquillet G, Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. Biometals. 2010;23:783-92.
18. Lue S-H, Wellenius GA, Wilker EH, Mostofsky E, Mittleman MA: Residential proximity to major roadways and renal function. Journal of Epidemiology and Community Health. 2013;67:629-634.
19. Nemmar A, Al-Salam S, Zia S, Yasin J, Al Husseni I, Ali BH: Diesel exhaust particles in the lung aggravate experimental acute renal failure. Toxicological Sciences. 2010;113:267-277.
20. Yan Y-H, Chou CC-K, Wang J-S, Tung C-L, Li Y-R, Lo K, Cheng T-J. Subchronic effects of inhaled ambient particulate matter on glucose homeostasis and target organ damage in a type 1 diabetic rat model. Toxicol Appl Pharmacol. 2014;281:211-20.
21. Ulrich MM, Alink GM, Kumarathasan P, Vincent R, Boere AJF, Cassee FR. Health effects and time course of particulate matter on the cardiopulmonary system in rats with lung inflammation. J Toxicol Environ Health A. 2002;65:1571-95.
22. Alfaro-Moreno E, Garcia-Cuellar C, De Vizcaya Ruiz A, Rojas-Bracho L, Osornio-Vargas AR: Cellular Mechanisms behind Particulate Matter Air Pollution Related Health Effects. Air Pollution: Health & Environmental Impacts, edited by: Gurjar, R, Molina, LT, and Ojha, CSP, Taylor & Francis 2010:249-274
23. Gottipolu RR, Landa ER, Schladweiler MC, McGee JK, Ledbetter AD, Richards JH, Wallenborn GJ, Kodavanti UP: Cardiopulmonary responses of intratracheally instilled tire particles and constituent metal components. Inhalation Toxicology. 2008;5:473-484.
24. Gottipolu RR, Landa ER, Schladweiler MC, McGee JK, Ledbetter AD, Richards JH, Wallenborn GJ, Kodavanti UP: Cardiopulmonary responses of intratracheally instilled tire particles and constituent metal components. Inhalation toxicology 2008
25. Alfaro-Moreno E, Torres V, Miranda J, Martínez L, García-Cuellar C, Nawrot TS, Vanaudenaerde B, Hoet P, Ramírez-López P, Rosas I. Induction of IL-6 and inhibition of IL-8 secretion in the human airway cell line Calu-3 by urban particulate matter collected with a modified method of PM sampling. Environ Res. 2009;109:528-35.
26. Pope 3rd C, Bates DV, Raizenne ME. Health effects of particulate air pollution: time for reassessment? Environ Health Perspect. 1995;103:472.
27. Dockery DW. Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ Health Perspect. 2001;109:483.
28. Obot CJ, Morandi MT, Beebe TP, Hamilton RF, Holian A. Surface components of airborne particulate matter induce macrophage apoptosis through scavenger receptors. Toxicol Appl Pharmacol. 2002;184:98-106.
29. Aoshiba K, Tamaoki J, Nagai A. Acute cigarette smoke exposure induces apoptosis of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1392-401.
30. Tamagawa E, Bai N, Morimoto K, Gray C, Mui T, Yatera K, Zhang X, Xing L, Li Y, Laher I. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol. 2008;295:L79-85.
31. Bai N, Kido T, Suzuki H, Yang G, Kavanagh TJ, Kaufman JD, Rosenfeld ME, van Breemen C, van Eeden SF. Changes in atherosclerotic plaques induced by inhalation of diesel exhaust. Atherosclerosis. 2011;216:299-306.
32. Greene K, King T, Kuroki Y, Bucher-Bartelson B, Hunninghake G, Newman L, Nagae H, Mason R. Serum surfactant proteins-A and-D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002;19:439-46.
33. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J. 1999;13:1455-76.
34. Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY, McCormack FX. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem. 2000;275:38848-55.
35. Szabo, Z., Alachkar, N., Xia, J., Mathews, W. B., & Rabb, H. Molecular imaging of the kidneys. Seminars in Nuclear Medicine. 2011;41:20-28.
36. Szabo Z, Alachkar N, Xia J, Mathews WB, Rabb H. Molecular imaging of the kidneys. In: Seminars in nuclear medicine.: Elsevier; 2011. p. 20-8.
37. Dibona GF. Neural control of renal function: cardiovascular implications. Hypertension. 1989;13:539-48.
38. Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R. Ambient pollution and heart rate variability. Circulation. 2000;101:1267-73.
39. Corey LM, Baker C, Luchtel DL. Heart-rate variability in the apolipoprotein E knockout transgenic mouse following exposure to Seattle particulate matter. J Toxicol Environ Health A. 2006;69:953-65.
40. DiBona GF. Physiology in perspective: The Wisdom of the Body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol. 2005;289:R633-41.
41. Dibona GF. Nervous kidney interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension. 2000;36:1083-8.
42. McKinley MJ, Johnson AK. The physiological regulation of thirst and fluid intake. Physiology. 2004;19:1-6.
43. Boucher RC. Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends In Molecular Medicine. 2007;13:231-40.
44. Lorenz JM. Fluid and electrolyte therapy and chronic lung disease. Current Opinion In Pediatrics. 2004;16:152-6.
45. Grossfeld, G. D., Wolf Jr, J. S., Litwin, M. S., Hricak, H., Shuler, C. L., Agerter, D. C., & Carroll, P. R. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. American Family Physician. 2001;63:1145-1154.
46. Grossfeld GD, Wolf Jr JS, Litwin MS, Hricak H, Shuler CL, Agerter DC, Carroll PR: Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Urology 2001, 3.
47. Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005;16:3728-35.
48. Amighi J, Hoke M, Mlekusch W, Schlager O, Exner M, Haumer M, Pernicka E, Koppensteiner R, Minar E, Rumpold H. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke. 2011;42:1826-33.
49. Endre ZH, Westhuyzen J. Early detection of acute kidney injury: Emerging new biomarkers (Review Article). Nephrology. 2008;13:91-8.
50. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008;23:2151-7.
51. Mori Y, Matsubara H, Murasawa S, Kijima K, Maruyama K, Tsukaguchi H, Okubo N, Hamakubo T, Inagami T, Iwasaka T. Translational regulation of angiotensin II type 1A receptor role of upstream AUG triplets. Hypertension. 1996;28:810-7.
52. Seino M, Abe K, OTSTJKA Y, Saito T, IROKAWA N, YASUJIMA M, Ciba S, Yoshinaga K. Urinary kallikrein excretion and sodium metabolism in hypertensive patients. Tohoku J Exp Med. 1975;116:359-67.
53. Iwai N, Yasui N, Naraba H, Tago N, Yamawaki H, Sumiya H. Klk1 as one of the genes contributing to hypertension in Dahl salt-sensitive rat. Hypertension. 2005;45:947-53.
54. Margolius HS, Geller R, PISANO JJ, SJOERDSMA A. Altered urinary kallikrein excretion in rats with hypertension. Circ Res. 1972;30:358-62.
55. Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol. 2005;90:291-8.
56. Bledsoe G, Crickman S, Mao J, Xia C-F, Murakami H, Chao L, Chao J. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrol Dial Transplant. 2006;21:624-33.
57. Michael IP, Kurlender L, Memari N, Yousef GM, Du D, Grass L, Stephan C, Jung K, Diamandis EP. Intron retention: a common splicing event within the human kallikrein gene family. Clin Chem. 2005;51:506-15.
58. Tschöpe C, Heringer-Walther S, Walther T. Regulation of the kinin receptors after induction of myocardial infarction: a mini-review. Braz J Med Biol Res. 2000;33:701-8.
59. Kuhr F, Lowry J, Zhang Y, Brovkovych V, Skidgel R. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides. 2010;44:145-54.
60. Marin-Castano ME, Schanstra JP, Praddaude F, Pesquero JB, Ader J-L, Girolami J-P, Bascands J-L. Differential induction of functional B1-bradykinin receptors along the rat nephron in endotoxin induced inflammation. Kidney Int. 1998;54:1888-98.
61. Fujii T, Hayashi S, Hogg JC, Vincent R, Van Eeden SF. Particulate matter induces cytokine expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2001;25:265-71.
62. Li N, Wang M, Oberley TD, Sempf JM, Nel AE. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. The Journal of Immunology. 2002;169:4531-41.
63. Graziani G, Bordone G, Bellato V, Finazzi S, Angelini C, Badalamenti S, Nephrology GdSTdiacotISo. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study. J Nephrol. 2006;19:176.
64. Dennen P, Altmann C, Kaufman J, Klein CL, Andres-Hernando A, Ahuja NH, Edelstein CL, Cadnapaphornchai MA, Keniston A, Faubel S. Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. Crit Care. 2010;14:R181.
65. Banas B, Luckow B, MÖLLER M, Klier C, Nelson PJ, Schadde E, Brigl M, Halevy D, HOLTHÖFER H, Reinhart B. Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol. 1999;10:2314-22.
66. Schwarz M, Radeke HH, Resch K, Uciechowski P. Lymphocyte-derived cytokines induce sequential expression of monocyte-and T cell-specific chemokines in human mesangial cells. Kidney Int. 1997;52:1521-31.
67. Segerer S, Nelson PJ, SCHLÖNDORFF D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol. 2000;11:152-76.
68. Humphreys B. D: Investigating the process of renal epithelial repair to develop new therapies. In: Little MH, editor: Kidney Development, Disease, Repair and Regeneration. Academic Press. 2015. p. 381-390.
69. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62:237-44.
70. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Investig. 1992;90:1.
71. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. The Journal of Immunology. 2004;172:2629-35.
72. Knotek M, Rogachev B, Wang W, Ecder T, Melnikov V, Gengaro PE, Esson M, Edelstein CL, Dinarello CA, Schrier RW. Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int. 2001;59:2243-9.
73. Rylander R. Review: Endotoxin in the environment-exposure and effects. J Endotoxin Res. 2002;8:241-52.
74. Klein CL, Hoke TS, Fang W-F, Altmann CJ, Douglas IS, Faubel S. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int. 2008;74:901-9.
75. Mehta AJ, Zanobetti A, Bind M, Kloog I, Koutrakis P, Sparrow D, Vokonas PS, Schwartz JD: Long-Term Exposure to Ambient Fine Particulate Matter and Renal Function in Older Men: The VA Normative Aging Study. Environmental Health Perspectives 2016; 124: doi: 10.1289/ehp.1510269.